Literature DB >> 2031874

Biochemical profile of propionyl-L-carnitine.

W C Hülsmann1.   

Abstract

This article briefly discusses biochemical reactions involved in the metabolism of propionate, propionyl-CoA, and propionyl-L-carnitine in the heart. The aim is to understand the way in which propionyl-L-carnitine can exert a protective effect on the ischemic/reperfused heart. The protection of the plasmalemma by propionyl-L-carnitine during acidosis of the heart is also discussed. One protective mechanism is based on the ability of propionate to replenish mitochondria with dicarboxylic acid intermediates of the citric acid cycle and to increase the cellular content of carnitine, both of which may stimulate the generation of energy in the postischemic reperfusion phase. Another mechanism presumes a stabilizing action of acylcarnitines upon biomembranes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2031874     DOI: 10.1007/bf00128237

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  13 in total

1.  The effects of propionylcarnitine taurine on cardiac performance in aerobic and ischemic myocardium.

Authors:  F Molaparast-Saless; S H Nellis; A J Liedkte
Journal:  J Mol Cell Cardiol       Date:  1988-01       Impact factor: 5.000

2.  Protection by acyl-carnitines and phenylmethylsulfonyl fluoride of rat heart subjected to ischemia and reperfusion.

Authors:  W C Hülsmann; M L Dubelaar; J M Lamers; F Maccari
Journal:  Biochim Biophys Acta       Date:  1985-10-30

3.  Early damage of vascular endothelium during cardiac ischaemia.

Authors:  W C Hülsmann; M L Dubelaar
Journal:  Cardiovasc Res       Date:  1987-09       Impact factor: 10.787

4.  Regulation of fatty acid utilization in heart. Role of the carnitine-acetyl-CoA transferase and carnitine-acetyl carnitine translocase system.

Authors:  J A Idell-Wenger; L W Grotyohann; J R Neely
Journal:  J Mol Cell Cardiol       Date:  1982-07       Impact factor: 5.000

Review 5.  Transport and function of L-carnitine and L-propionylcarnitine: relevance to some cardiomyopathies and cardiac ischemia.

Authors:  N Siliprandi; F Di Lisa; A Pivetta; G Miotto; D Siliprandi
Journal:  Z Kardiol       Date:  1987

6.  Organ and intracellular localization of short-chain acyl-CoA synthetases in rat and guinea-pig.

Authors:  H R Scholte; P H Groot
Journal:  Biochim Biophys Acta       Date:  1975-12-17

7.  Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation.

Authors:  D J Paulson; J Traxler; M Schmidt; J Noonan; A L Shug
Journal:  Cardiovasc Res       Date:  1986-07       Impact factor: 10.787

8.  Differential effects of L-propionylcarnitine on the electrical and mechanical properties of guinea pig ventricular muscle in normal and acidic conditions.

Authors:  M Aomine; M Arita
Journal:  J Electrocardiol       Date:  1987-11       Impact factor: 1.438

9.  Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts.

Authors:  J R Neely; L W Grotyohann
Journal:  Circ Res       Date:  1984-12       Impact factor: 17.367

10.  Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts.

Authors:  A J Liedtke; L DeMaison; S H Nellis
Journal:  Am J Physiol       Date:  1988-07
View more
  4 in total

1.  Comparison of mouse urinary metabolic profiles after exposure to the inflammatory stressors γ radiation and lipopolysaccharide.

Authors:  Evagelia C Laiakis; Daniel R Hyduke; Albert J Fornace
Journal:  Radiat Res       Date:  2011-11-30       Impact factor: 2.841

Review 2.  Propionyl-L-carnitine.

Authors:  L R Wiseman; R N Brogden
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

3.  Assessment of the cardiostimulant action of propionyl-L-carnitine on chronically volume-overloaded rat hearts.

Authors:  Z el Alaoui-Talibi; N Bouhaddioni; J Moravec
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

4.  Protection of the ischemic diabetic heart by L-propionylcarnitine therapy.

Authors:  D J Paulson; A L Shug; J Zhao
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.